Lumos Diagnostics Holdings Limited

ASX:LDX Stock Report

Market Cap: AU$20.8m

Lumos Diagnostics Holdings Management

Management criteria checks 2/4

Lumos Diagnostics Holdings' CEO is Doug Ward, appointed in Jun 2022, has a tenure of 2.25 years. total yearly compensation is $773.94K, comprised of 62.7% salary and 37.3% bonuses, including company stock and options. directly owns 0.084% of the company’s shares, worth A$17.58K. The average tenure of the management team and the board of directors is 2.7 years and 3.8 years respectively.

Key information

Doug Ward

Chief executive officer

US$773.9k

Total compensation

CEO salary percentage62.7%
CEO tenure2.3yrs
CEO ownership0.08%
Management average tenure2.7yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

There Is A Reason Lumos Diagnostics Holdings Limited's (ASX:LDX) Price Is Undemanding

Aug 29
There Is A Reason Lumos Diagnostics Holdings Limited's (ASX:LDX) Price Is Undemanding

Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)

Jan 03
Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)

The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More

Jul 04
The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More

Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates

Jul 12
Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates

CEO Compensation Analysis

How has Doug Ward's remuneration changed compared to Lumos Diagnostics Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024US$774kUS$485k

-US$9m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023n/an/a

-US$9m

Sep 30 2023n/an/a

-US$9m

Jun 30 2023US$665kUS$415k

-US$9m

Mar 31 2023n/an/a

-US$25m

Dec 31 2022n/an/a

-US$41m

Sep 30 2022n/an/a

-US$43m

Jun 30 2022US$472kUS$14k

-US$46m

Compensation vs Market: Doug's total compensation ($USD773.94K) is above average for companies of similar size in the Australian market ($USD311.19K).

Compensation vs Earnings: Doug's compensation has increased whilst the company is unprofitable.

CEO

Doug Ward

2.3yrs

Tenure

US$773,939

Compensation

Mr. Douglas Ward, also known as Doug, serves as Chief Executive Officer of Lumos Diagnostics Holdings Limited since June 20, 2022 and its Managing Director and Director since July 13, 2023. He was Chief Ex...

Leadership Team

NamePositionTenureCompensationOwnership
Douglas Ward
CEO, MD & Director2.3yrsUS$773.94k0.084%
$ 17.6k
Barrie Lambert
Chief Financial Officer2.6yrsUS$385.34kno data
Sacha Dopheide
Chief Technology Officerno datano datano data
Jennifer Christiansen
Vice President of Corporate Marketing & Communications3.7yrsno datano data
Sarah Glubka
Senior Director of Human Resources3.8yrsno datano data
Paul Kase
Senior Vice President of Commercial Operations2.7yrsno datano data
Tracy Weimar
Company Secretaryno datano datano data

2.7yrs

Average Tenure

Experienced Management: LDX's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Douglas Ward
CEO, MD & Director1.2yrsUS$773.94k0.084%
$ 17.6k
Samuel Lanyon
Non-Executive Chairman5.7yrsUS$182.78k0.22%
$ 45.5k
Bronwyn Le Grice
Independent Director3.8yrsUS$65.51k0.020%
$ 4.1k
Catherine Robson
Independent Director3.8yrsUS$61.88k0.24%
$ 49.5k
Jerome Adams
Strategic Healthcare Adviser & Member of Medical Advisory Board3yrsno datano data

3.8yrs

Average Tenure

Experienced Board: LDX's board of directors are considered experienced (3.8 years average tenure).